Groups
|
Categories
|
No. of Studies
|
Adjusted OR
|
95% CI
|
Heterogeneity within groups (I2)
|
P-difference between groups
|
---|
Study Design
|
Case–control
|
5
|
0.59
|
0.40-0.88
|
51
|
0.11
|
Cohort
|
4
|
0.84
|
0.71-1.00
|
0
|
Study Location
|
Asian
|
2
|
0.43
|
0.09-2.00
|
84
|
0.51
|
Western
|
7
|
0.72
|
0.58-0.89
|
18
|
Study Quality
|
High
|
4
|
0.84
|
0.71-1.00
|
0
|
0.11
|
Low
|
5
|
0.59
|
0.40-0.88
|
51
|
Dose–response
|
Middle tertilea
|
5
|
0.88
|
0.70-1.10
|
19
|
0.41
|
|
Highest tertilea
|
5
|
0.76
|
0.60-0.97
|
0
| |
-
ausing least active people as reference category [Abbreviations: EAC-Esophageal adenocarcinoma; ESCC-Esophageal squamous cell carcinoma].